Morning Trend | Ping An Biomedical continues to decline, is the main force's bottom-fishing window about to open?

Ping An Biomedical (PASW.US) has been hovering at low levels for several days, with evident capital hesitation. Community experts have been asking questions: "With the drop like this, will the main funds dare to smash the market to accumulate shares? Is the bottom-fishing opportunity coming soon?" Recently, Ping An Biomedical has been affected by revenue data, and the downward trend has been the main theme. The stock price has dipped to around $1.80, with technical support levels precarious and intraday trading sluggish. Community discussions are polarized; one group remains bearish, waiting for a breakdown to liquidate, while another group of "wolf pack" traders is closely watching for the moment when the main funds smash the market to prepare for a strike. From the perspective of North American data and capital flow, the controlling main funds have not yet significantly accumulated shares, but the bottom chips are starting to alternate, and the intention of capital to ambush at the bottom has increased. The likelihood of a "bounce from oversold conditions" due to continuous declines is gradually rising. If there is a sudden influx of large orders or a short-term increase in trading volume during the intraday session, it could trigger a fierce rebound. In terms of operation, it is crucial to pay attention to whether the $1.80 level can be maintained. If there is a sudden surge accompanied by increased volume, it would be a short-term strike opportunity. Otherwise, there is still a possibility of continued fluctuations at the bottom, and it is not advisable to take heavy positions until the main funds reveal their cards. The bottom-fishing window is just a line away; whether to profit or incur losses depends entirely on whether the main funds can act decisively in the intraday session